Celecoxib, rofecoxib, and acute temporary visual impairment

BMJ. 2003 Nov 22;327(7425):1214-5. doi: 10.1136/bmj.327.7425.1214.

Authors

David Morris Coulter¹, David Walter John Clark, Ruth Lesley Savage

Affiliation

¹ Intensive Medicines Monitoring Programme, New Zealand Pharmacovigilance Centre, Department of Preventive and Social Medicine, Dunedin School of Medicine, University of Otago, PO Box 913, Dunedin 9000, New Zealand. david.coulter@stonebow.otago.ac.nz

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't
Review

MeSH terms

Acute Disease
Aged
Aged, 80 and over
Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
Celecoxib
Cyclooxygenase Inhibitors / adverse effects*
Female
Humans
Lactones / adverse effects*
Male
Pain, Postoperative / prevention & control
Pyrazoles
Sulfonamides / adverse effects*
Sulfones
Vision Disorders / chemically induced*

Substances

Anti-Inflammatory Agents, Non-Steroidal
Cyclooxygenase Inhibitors
Lactones
Pyrazoles
Sulfonamides
Sulfones
rofecoxib
Celecoxib